UP Philippine General Hospital Division of Endocrinology, Diabetes & Metabolism Consensus Recommendations for In-Patient Management of Diabetes Mellitus among Persons with COVID-19

• Published in: Journal of the ASEAN Federation of Endocrine Societies 2020, Vol.35 (1), p.14-25
• Main Authors: Jimeno, Cecilia, Anonuevo-Cruz, Ma Cecille, Uy, Angelique Bea, Bacena, Adrian Oscar, Francisco, Mark David, Tiglao-Gica, Angelique Love, Bruno, Racquel, Corpuz, Diane Grace
• Format: Article
• Language: English
• Subjects: COVID-19; diabetes; in-patient management; SARS-COV-2
• ISSN: 0857-1074; 2308-118X
• DOI: 10.15605/jafes.035.01.05

Diabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19 much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available evidence that has been published regarding in-patient management of diabetes among patients with COVID-19. A comprehensive review of literature was done and recommendations have been made through a consensus of expert endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology, Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the disease and how persons with diabetes are affected by this virus.